Kings Point Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $195K | Hold |
2,940
| – | – | 0.02% | 204 |
|
|
2021
Q4 | $171K | Hold |
2,940
| – | – | 0.01% | 226 |
|
|
2021
Q3 | $177K | Hold |
2,940
| – | – | 0.02% | 209 |
|
|
2021
Q2 | $176K | Sell |
2,940
-100
| -3% | -$5.99K | 0.02% | 209 |
|
|
2021
Q1 | $151K | Sell |
3,040
-800
| -21% | -$39.7K | 0.01% | 214 |
|
|
2020
Q4 | $192K | Buy |
3,840
+731
| +24% | +$36.6K | 0.02% | 185 |
|
|
2020
Q3 | $170K | Buy |
3,109
+169
| +6% | +$9.24K | 0.02% | 186 |
|
|
2020
Q2 | $155K | Hold |
2,940
| – | – | 0.02% | 178 |
|
|
2020
Q1 | $131K | Hold |
2,940
| – | – | 0.02% | 186 |
|
|
2019
Q4 | $147K | Hold |
2,940
| – | – | 0.02% | 203 |
|
|
2019
Q3 | $131K | Hold |
2,940
| – | – | 0.02% | 193 |
|
|
2019
Q2 | $121K | Buy |
+2,940
| New | +$121K | 0.02% | 184 |
|
|
2018
Q4 | – | Sell |
-1,056
| Closed | -$42K | – | 351 |
|
|
2018
Q3 | $42K | Buy |
1,056
+56
| +6% | +$2.23K | 0.01% | 260 |
|
|
2018
Q2 | $35K | Hold |
1,000
| – | – | 0.01% | 267 |
|
|
2018
Q1 | $35K | Hold |
1,000
| – | – | 0.01% | 271 |
|
|
2017
Q4 | $35K | Hold |
1,000
| – | – | 0.01% | 264 |
|
|
2017
Q3 | $34K | Hold |
1,000
| – | – | 0.01% | 250 |
|
|
2017
Q2 | $34K | Hold |
1,000
| – | – | 0.01% | 246 |
|
|
2017
Q1 | $31K | Buy |
+1,000
| New | +$31K | 0.01% | 265 |
|
|
2015
Q1 | – | Sell |
-1,180
| Closed | -$42K | – | 360 |
|
|
2014
Q4 | $42K | Sell |
1,180
-1,000
| -46% | -$35.6K | 0.01% | 213 |
|
|
2014
Q3 | $78K | Hold |
2,180
| – | – | 0.02% | 156 |
|
|
2014
Q2 | $81K | Buy |
2,180
+180
| +9% | +$6.69K | 0.02% | 151 |
|
|
2014
Q1 | $65K | Hold |
2,000
| – | – | 0.02% | 154 |
|
|
2013
Q4 | $59K | Hold |
2,000
| – | – | 0.02% | 159 |
|
|
2013
Q3 | $52K | Hold |
2,000
| – | – | 0.02% | 170 |
|
|
2013
Q2 | $47K | Buy |
+2,000
| New | +$47K | 0.02% | 187 |
|